Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022

Christina E. Hoeve, Brechje de Gier, Anne J. Huiberts, Hester E. de Melker, Susan J.M. Hahné, Susan van den Hof, Mirjam J. Knol
doi: https://doi.org/10.1101/2023.01.10.23284386

Article usage

Article usage: January 2023 to August 2025

AbstractFullPdf
Jan 20233050118455
Feb 20231564550
Mar 20231394322
Apr 2023583113
May 20234827
Jun 20233068
Jul 20233224
Aug 202327116
Sep 20233576
Oct 20232754
Nov 202326142
Dec 20231212
Jan 20241881
Feb 20241374
Mar 20241722
Apr 20241263
May 20241124
Jun 20241567
Jul 20241515
Aug 20241026
Sep 20241776
Oct 2024732
Nov 20241622
Dec 20241612
Jan 2025712
Feb 202514236
Mar 2025311210
Apr 202549119
May 202522713
Jun 2025321711
Jul 2025261616
Aug 2025343
Back to top
Posted January 11, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022
Christina E. Hoeve, Brechje de Gier, Anne J. Huiberts, Hester E. de Melker, Susan J.M. Hahné, Susan van den Hof, Mirjam J. Knol
medRxiv 2023.01.10.23284386; doi: https://doi.org/10.1101/2023.01.10.23284386
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area